US$ 28.52
crazyleaf smgt glp 1 nano microneedle patch biggest companies Top 20 biopharmas' market cap up 4.3% in Q2 2024 as GLP-1 drug innovators hold top spots CrazyLeaf® SMGT-1 Nano örnálaplástur -
Description
GLP1 (glucagonlike peptide1) therapies that were originally developed to treat Type 2 diabetes, have moved into mainstream conversations about the positive affect GLP-1s have had on weight management

Impact on the food industry Companies across the food sector are paying close attention as consumer habits shift
/product/99/7475523/1.jpg?7369)
Between 2014 and now, prescriptions for these GLP-1 drugs have increased a whopping 300 percent

Once applied, these microneedles dissolve naturally , releasing GLP-1 in a steady, controlled manner over time without the spikes or dips often seen with injections
